BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

BrainsWay Ltd.NASDAQ: BWAY

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization growth accelerates

Q1 FY2026 depreciation & amortization of $465K rose 18.0% year over year, ahead of the -12.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 32.1% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.

Context

  • Depreciation & amortization amounted to 2.9% of revenue in FY2025, down 1.4 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +18.0% holds above the trailing-twelve-month pace of -12.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$465K+32.1% QoQ
Last fiscal yearDec 2025
$1.54M-13.2% YoY
LTMMar 2026
$1.61M-12.9% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.0%——
1 year-13.2%——
3-year CAGR+0.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
1.54M USD
Year-over-year change
-13.2%
4-year CAGR
-2.3%

Depreciation & Amortization vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's LTM Mar 2026 depreciation & amortization of $1.61M is the 2nd highest of the 4 companies compared; the peer median is $1.57M.
  • Its year-over-year change of -12.9% is the 3rd highest of 4, against a peer median of +36.1%.
  • Depreciation & amortization amounts to 2.9% of revenue for BWAY, versus a peer median of 2.2%.
BWAY Competitors Peer median
Depreciation & Amortization for BWAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
STIMNeuronetics, Inc.LTM Mar 2026$3.3M +36.1%+28.1%2.2%
BWAYBrainsWay Ltd.LTM Mar 2026$1.61M -12.9%+0.1%2.9%
NPCENeuroPace, Inc.LTM Mar 2026$1.57M -13.4%-13.3%1.6%
HSDTSolana CompanyLTM Mar 2026$672K +1192.3%+38.7%7.0%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding BWAY) $1.57M+36.1%+28.1%2.2%

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue29.66M27.18M31.79M41.02M52.23M
Cost of Revenue6.6M7.13M8.31M10.44M12.84M
Gross Profit23.06M20.05M23.48M30.58M39.39M
Gross Margin77.7%73.8%73.9%74.6%75.4%
Research & Development6.39M7.68M6.67M7.19M9.6M
Selling, General & Admin21.66M25.05M21.64M22M25.46M
Operating Expenses28.06M32.73M28.44M29.19M35.06M
Depreciation & Amortization1.69M1.53M1.34M1.77M1.54M
EBITDA(4.67M)(11.45M)(2.56M)5.36M11.46M
EBITDA Margin-15.8%-42.1%-8.1%13.1%21.9%
Operating Income(5M)(12.68M)(4.96M)1.39M4.32M
Operating Margin-16.9%-46.7%-15.6%3.4%8.3%
Interest Income225K1.11M2.17M2.48M5.64M
Interest Expense141K68K298K1.36M2.23M
Other Income / Expenses(1.42M)(351K)1.01M2.07M3.39M
Income Before Tax(6.42M)(13.03M)(3.95M)3.46M7.71M
Pre-Tax Margin-21.6%-48.0%-12.4%8.4%14.8%
Income Tax Expense43K315K251K538K77K
Net Income(6.46M)(13.35M)(4.2M)2.92M7.63M
Net Margin-21.8%-49.1%-13.2%7.1%14.6%
EPS (Basic)(0.21)(0.43)(0.13)0.090.40
EPS (Diluted)(0.21)(0.43)(0.13)0.090.36
Weighted Avg Shares31.15M32.98M33.16M33.97M19.08M
Weighted Avg Shares (Diluted)31.15M32.98M33.16M34.77M21.21M

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.